Covid-19 roundup: J&J launch­ing new PhII vac­cine tri­als in Eu­rope; Ab­bott scores $760M test­ing kit or­der from HHS

As J&J plans to roll out Phase III test­ing for its Covid-19 vac­cine some­time next month, the big phar­ma is plan­ning ad­di­tion­al Phase II tri­als in the in­ter­im.

J&J will be­gin mid-stage test­ing in Spain next week, the coun­try’s health min­is­ter said on Fri­day, as well as in Ger­many and the Nether­lands per a Reuters re­port. The tri­al will take two months to com­plete and en­roll about 550 peo­ple across the three na­tions, fo­cus­ing on healthy in­di­vid­u­als aged 18 to 55 in ad­di­tion to some old­er than 65.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER